FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics FDA Peptide Reclassification 2026: What It Means for Providers The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York GOP lawmakers ask RFK Jr. to make FDA unleash risky peptides like BPC 157 The Niche